James DeMesa
President at Emerald Health Pharmaceuticals, Inc.
Net worth: - $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Punit Dhillon | M | 44 |
Emerald Health Pharmaceuticals, Inc.
 Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | 13 years |
| K. David Campagnari | M | - |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.
Induce Biologics, Inc.
 Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | 9 years |
| James Heppell | M | 69 |
Emerald Health Pharmaceuticals, Inc.
Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | - |
| Gaetano Morello | M | 62 |
Emerald Health Pharmaceuticals, Inc.
Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | - |
| Alain P. Rolland | M | 64 |
Emerald Health Pharmaceuticals, Inc.
Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | 6 years |
| Neil Belmore | M | - |
Induce Biologics, Inc.
Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | - |
| Rob R. McEwen | M | - |
Induce Biologics, Inc.
Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | - |
| Sandra Aung | M | - | 4 years | |
| Bridget O'Keeffe | M | - | 3 years | |
| David Canton | M | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ronald C. Dela Cruz | M | 48 | 3 years | |
| Veronica Vallejo | F | 51 | 4 years | |
| David Allan | M | 82 | 3 years | |
| Niclas Stiernholm | M | - | 8 years | |
| Margaret Dalesandro | M | 77 | 2 years | |
| Robert Arch | M | 58 | 1 years | |
| James Parsons | M | 58 | 10 years | |
| Robert A. Uger | M | 53 | 8 years | |
| Daniel O'Connor | M | 59 | 4 years | |
| Sharron E. Gargosky | M | 59 | - | |
| Avtar Dhillon | M | 62 | 12 years | |
| Kellie Malloy Foerter | F | 55 | 2 years | |
| Sara Bonstein | F | 43 | 2 years | |
| Sheela Mohan-Peterson | F | 61 | 4 years | |
| Kevin Smith | M | 53 | 3 years | |
| Robert L. Kirkman | M | 75 | 8 years | |
| Michael Dennis Price | M | 66 |
Teva Spanish Holdco, Inc.
 Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH. | 14 years |
| Richard B. Slansky | M | 67 | 3 years | |
| Calvin Stiller | M | 83 | 8 years | |
| Michael B. Cross | M | 59 | 4 years | |
| Rick D. Hangartner | M | - |
University of South Florida
| 6 years |
| Alan Moore | M | - | 4 years | |
| Annalisa Jenkins | M | 58 | 1 years | |
| Penka Petrova | M | 56 | 8 years | |
| Gregory Mayes | M | 55 | 1 years | |
| Ernest Kitt | M | - | - | |
| Judith C. Norstrud | F | 55 |
University of South Florida
| 6 years |
| Jean S. Campbell | M | - | - | |
| Brian Leuthner | M | 59 | - | |
| R. Dean Peterson | M | - | 4 years | |
| Robert Pierce | M | 59 | - | |
| Robert E. Ward | M | 66 | 3 years | |
| Robert J. Troell | M | - |
University of South Florida
| 8 years |
| Paul M. Goldfarb | M | - | - | |
| Robert W. Ashworth | M | - | 3 years | |
| Joon Kim | M | 58 | 5 years | |
| Luke Beshar | M | 65 | 7 years | |
| Thomas Reynolds | M | 65 | 7 years | |
| Valerie D. Riddle | M | 63 |
University of South Florida
| 8 years |
| Gordon Gillette | M | 63 |
University of South Florida
| 6 years |
| Kim Jaffe | M | - | - | |
| AnnKatrin Petersen-Jappelli | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 4 years |
| Mustafa Sagun | M | 58 |
University of South Florida
| 5 years |
| Michael G. Moore | M | - | 7 years | |
| Herbert Lyerly | M | 65 | 3 years | |
| Anthony Maida | M | 59 | 6 years | |
| Sean A. F. Peel | M | - |
Induce Biologics, Inc.
Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | - |
| Bruce A. Schmidt | M | 68 |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 years |
| Henry Friesen | M | 90 | - | |
| Christopher G. Twitty | M | 52 | 5 years | |
| Rob Paulsson | M | - |
University of South Florida
| 4 years |
| James M. McGrew | M | - |
University of South Florida
| 4 years |
| Cynthia Lawrence | F | - |
University of South Florida
| 3 years |
| Amelia O. Pulliam | F | 52 |
University of South Florida
| 4 years |
| Warrick A. Morgan | M | 59 |
University of South Florida
| 4 years |
| Achmad Suherman Kartasasmita | M | 64 |
University of South Florida
| 4 years |
| Jeff Zysek | M | - |
University of South Florida
| 4 years |
| Andrea Colender | F | - |
University of South Florida
| 4 years |
| Shuk Kwan Chan | F | 59 |
University of South Florida
| 4 years |
| Ken S. Zuckerberg | M | - |
University of South Florida
| 4 years |
| Jae-Chul Yoon | M | 75 |
University of South Florida
| 1 years |
| Rohana binti Abdul Majid | F | 65 |
University of South Florida
| 4 years |
| Christopher J. Floyd | M | 61 |
University of South Florida
| 4 years |
| Anthony Warren Welch | M | - |
University of South Florida
| 4 years |
| Dane C. Urie | M | - |
University of South Florida
| 4 years |
| Kern Davis | M | 69 |
University of South Florida
| 2 years |
| Dave G. Shell | M | - |
University of South Florida
| 4 years |
| Michael Dreyer | M | - |
University of South Florida
| 2 years |
| Scott Renner | M | 55 |
University of South Florida
| 2 years |
| James P. Dietz | M | 58 |
University of South Florida
| 4 years |
| Joseph McFadden | M | - |
University of South Florida
| 4 years |
| Michael Novielli | M | 58 |
University of South Florida
| 4 years |
| Harald Hvideberg | M | 56 |
University of South Florida
| 4 years |
| Steve M. Krupa | M | 59 |
University of South Florida
| 5 years |
| Aris Bogdaneris | M | 60 |
University of South Florida
| 4 years |
| Kirk Sawyer | M | - |
University of South Florida
| 1 years |
| Lowe Morrison | M | - |
University of South Florida
| 6 years |
| Douglas E. Klaymeier | M | - |
University of South Florida
| 4 years |
| Steve Charest | M | 59 |
University of South Florida
| 4 years |
| Albert McLelland | M | 66 |
University of South Florida
| 4 years |
| Michael W. Perry | M | - |
University of South Florida
| 4 years |
| Ron L. Tambasco | M | - |
University of South Florida
| 4 years |
| Thomas Conigliaro | M | - |
University of South Florida
| 2 years |
| Audra Moran | F | - |
University of South Florida
| 4 years |
| Jeannine Dunn | F | - |
University of South Florida
| 4 years |
| Felice C. Wagner | F | - |
University of South Florida
| 4 years |
| Dean Head | M | - |
University of South Florida
| 4 years |
| Garrison Hasara | M | 54 |
University of South Florida
| 4 years |
| Brian K. Mashburn | M | - |
University of South Florida
| 4 years |
| Keith Stoloff | M | - |
University of South Florida
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 81 | 81.00% |
| Canada | 19 | 19.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James DeMesa
- Personal Network
